InsidersTradesSigma
Track the Clover Biopharmaceuticals, Ltd. - B share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Clover Biopharmaceuticals, Ltd. - B has published 35 public disclosures. Market capitalisation: €2.1bn. The latest transaction was filed on 21 July 2026 (Sale). Among the most active insiders: Liang Peng. All data is free.
35
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
€622,892
14 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 July 2026
Declarations35 total
500,000 shares@ HK$1.800.044% mcap16.1% of flowShareXHKGHKEX:DA20260721E00133
50,000 shares@ HK$1.550.0041% mcap1.7% of flowShareXHKGHKEX:DA20260715E00487
50,000 shares@ HK$1.720.0038% mcap2.2% of flowShareXHKGHKEX:DA20260707E00164
50,000 shares@ HK$1.730.0046% mcap2.1% of flowShareXHKGHKEX:DA20260701E00013
100,000 shares@ HK$1.640.0088% mcap3.9% of flowShareXHKGHKEX:DA20260701E00012
100,000 shares@ HK$1.8110.0097% mcap4.2% of flowShareXHKGHKEX:DA20260629E00014
14,500 sharesShareXHKGHKEX:DA20260617E00208
47,500 shares@ HK$2.460.0056% mcap2.5% of flowShareXHKGHKEX:DA20260601E00004
52,500 shares@ HK$2.4390.0062% mcap2.7% of flowShareXHKGHKEX:DA20260601E00003
600,000 shares@ HK$3.160.083% mcap48.0% of flowShareXHKGHKEX:DA20260424E00084
300,000 shares@ HK$3.120.041% mcap23.6% of flowShareXHKGHKEX:DA20260417E00037
49,000 sharesShareXHKGHKEX:DA20260409E00113
49,000 sharesShareXHKGHKEX:DA20260409E00086
383,000 sharesShareXHKGHKEX:DA20260409E00099
1,086,000 sharesShareXHKGHKEX:DA20260409E00098
1,326,875 sharesShareXHKGHKEX:DA20260409E00100
189,500 sharesShareXHKGHKEX:DA20260409E00094
572,500 sharesShareXHKGHKEX:DA20260409E00092
49,000 sharesShareXHKGHKEX:DA20260409E00117
49,000 sharesShareXHKGHKEX:DA20260409E00126
2,412,875 sharesShareXHKGHKEX:DA20260409E00096
49,000 sharesShareXHKGHKEX:DA20260409E00105
49,000 sharesShareXHKGHKEX:DA20260409E00120
9,840 sharesShareXHKGHKEX:DA20260403E00017
500 sharesShareXHKGHKEX:DA20260403E00016
25 of 35 declarations
关于 Clover Biopharmaceuticals, Ltd. - B
Clover Biopharmaceuticals, Ltd. 是一家生物制药公司，专注于开发传染病疫苗和疗法。该公司在香港证券交易所上市，股票代码为 XHKG。